ScoreWhy is Hybio Pharmaceutical Co.. Ltd. ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0%
- Poor long term growth as Net Sales has grown by an annual rate of 8.07% and Operating profit at 15.82% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 70.21%, its profits have risen by 94.7%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Hybio Pharmaceutical Co.. Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Hybio Pharmaceutical Co.. Ltd.
46.8%
1.40
65.55%
China Shanghai Composite
14.77%
1.01
15.10%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
8.07%
EBIT Growth (5y)
15.82%
EBIT to Interest (avg)
-3.92
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
2.65
Sales to Capital Employed (avg)
0.29
Tax Ratio
16.39%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0.88%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
21.34
EV to EBIT
379.12
EV to EBITDA
113.73
EV to Capital Employed
7.11
EV to Sales
19.53
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
1.88%
ROE (Latest)
-3.47%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend40What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 113.35 MM
NET PROFIT(Q)
At CNY 69.87 MM has Grown at 255.79%
ROCE(HY)
Highest at -13.67%
RAW MATERIAL COST(Y)
Fallen by -21.89% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 4.1%
NET SALES(Q)
Highest at CNY 308.33 MM
OPERATING PROFIT(Q)
Highest at CNY 97.47 MM
PRE-TAX PROFIT(Q)
Highest at CNY 76.35 MM
EPS(Q)
Highest at CNY 0.08
-7What is not working for the Company
DEBT-EQUITY RATIO
(HY)
Highest at 264.92 %
INTEREST(Q)
At CNY 25.25 MM has Grown at inf%
CASH AND EQV(HY)
Lowest at CNY 59.54 MM
INVENTORY TURNOVER RATIO(HY)
Lowest at 0%
Here's what is working for Hybio Pharmaceutical Co.. Ltd.
Net Sales
At CNY 308.33 MM has Grown at 111.13%
over average net sales of the previous four periods of CNY 146.04 MMMOJO Watch
Near term sales trend is extremely positive
Net Sales (CNY MM)
Pre-Tax Profit
At CNY 76.35 MM has Grown at 281.23%
over average net sales of the previous four periods of CNY -42.13 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 69.87 MM has Grown at 255.79%
over average net sales of the previous four periods of CNY -44.85 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Operating Cash Flow
Highest at CNY 113.35 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Net Sales
Highest at CNY 308.33 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Operating Profit
Highest at CNY 97.47 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CNY MM)
Pre-Tax Profit
Highest at CNY 76.35 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY 69.87 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY 0.08
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Debtors Turnover Ratio
Highest at 4.1%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -21.89% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Hybio Pharmaceutical Co.. Ltd.
Interest
At CNY 25.25 MM has Grown at inf%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Debt-Equity Ratio
Highest at 264.92 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Cash and Eqv
Lowest at CNY 59.54 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Inventory Turnover Ratio
Lowest at 0%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
